RhemaStem is a biotech company specializing in the research and development of effective innovative drugs in the field of colorectal cancer and other solid cancers. Headquartered in Monza, Italy, RhemaStem provides an advanced and a unique platform technology to address a critical shortcoming in existing methods of isolation and production of tumor and normal stem cells for drug discovery and development.

RhemaStem’s goal is to cure colorectal cancer and other solid cancers with our unique expertise and skills in the area of cancer and normal stem cells, an approach that we are promoting with great conviction. RhemaStem offers also consulting services in the area of solid cancer stem cells: Colon, Lungs, Breast, Prostrate, Ovary, Brain, Circulating blood cells and other cancers.

Below is a guest article from RhemaStem about the virtually unlimited expansion of clinically-relevant colon cancer tumorigenic cells. [Read more…]